Cargando…
Enfuvirtide antiretroviral therapy in HIV-1 infection
It has been over 25 years since the first diagnosis of what would be known as AIDS. Although great strides in anti-HIV therapeutics have been made, there is still a great need for antiretrovirals that are effective against drug-resistant HIV. Enfuvirtide (ENF) is the first of a new class of fusion i...
Autores principales: | Kitchen, Christina MR, Nuño, Miriam, Kitchen, Scott G, Krogstad, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504070/ https://www.ncbi.nlm.nih.gov/pubmed/18728846 |
Ejemplares similares
-
In Vivo Validation of a Bioinformatics Based Tool to Identify Reduced Replication Capacity in HIV-1
por: Kitchen, Christina M.R, et al.
Publicado: (2010) -
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
por: Kravchenko, AV, et al.
Publicado: (2010) -
Effectiveness of enfuvirtide in a cohort of highly antiretroviral-experienced HIV-1-infected patients in Mexico
por: Huerta-García, Gloria, et al.
Publicado: (2014) -
Stem-Cell-Based Gene Therapy for HIV Infection
por: Zhen, Anjie, et al.
Publicado: (2013) -
HIV-1 Fusion Inhibitor Peptides Enfuvirtide and T-1249 Interact with Erythrocyte and Lymphocyte Membranes
por: Matos, Pedro M., et al.
Publicado: (2010)